FrancophonIA/ELRC3.0 huggingface dataset:
English: In a 12 month recurrence prevention study in manic episode patients who achieved remission on olanzapine and were then randomised to olanzapine or placebo, olanzapine demonstrated statistically significant superiority over placebo on the primary endpoint of bipolar recurrence.
Danish: I et 12 måneders studie af forebyggelse af tilbagefald i de maniske episoder blev patienter, som havde opnået bedring ved brug af olanzapin, randomiseret på olanzapin eller placebo.
English: Coated tablet
Danish: Overtrukne tabletter
English: Blood and the lymphatic system disorders Eosinophilia
Danish: Blod og lymfesystem
English: Powder for Solution for Injection
Danish: Pulver til injektionsvæske, opløsning
English: Hepatobiliary disorders Transient, asymptomatic elevations of hepatic aminotransferases (ALT, AST), especially in early treatment (see section
Danish: Forbigående, asymptomatisk forhøjede leveraminotransferaser (ALAT, ASAT), særlig initialt i behandlingen (se pkt.
English: • If you know that you may have salt depletion as a result of prolonged severe diarrhoea and vomiting
Danish: • Saltmangel som følge af langvarig alvorlig diarré og opkastning eller brug af vanddrivende medicin (diuretika)
English: Only take other medicines while you are on ZYPREXA if your doctor tells you that you can. You might feel drowsy if ZYPREXA is taken in combination with antidepressants or medicines taken for anxiety or to help you sleep (tranquillisers).
Danish: Du kan komme til at føle dig døsig, hvis ZYPREXA tages sammen med depressionsmidler eller medicin til behandling af angst eller søvnløshed (sovepiller).
English: 1 mg olanzapine is retained in the vial and syringe, thus allowing delivery of 10mg olanzapine.
Danish: Hvis 2,0 ml opløsning trækkes op i en sprøjte, tilbageholdes 1 mg olanzapin i hætteglas og sprøjte, hvorved 10 mg olanzapin kan afgives.
English: How to take ZYPREXA
Danish: Sådan skal du tage ZYPREXA
English: Consult your doctor if your symptoms return but do not stop taking ZYPREXA unless your doctor tells you to.
Danish: Din læge vil fortælle dig, hvor mange ZYPREXA tabletter, du skal tage og i hvor lang tid, du skal tage dem. Dagsdosis for ZYPREXA er mellem 5 mg og 20 mg. Konsulter din læge, hvis dine symptomer vender tilbage, men stop ikke med at tage ZYPREXA, medmindre din læge siger det.
English: ZYPREXA 2.5 mg coated tablets
Danish: ZYPREXA 2,5 mg overtrukne tabletter
English: • The active substance is olanzapine.
Danish: ZYPREXA indeholder: - Aktivt stof: Olanzapin.
English: In patients with a manic or mixed episode of bipolar disorder, olanzapine demonstrated superior efficacy to placebo and valproate semisodium (divalproex) in reduction of manic symptoms over
Danish: Hos patienter med maniske eller blandede episoder af bipolar sindslidelse havde olanzapin, administreret oralt, overlegen effekt i reduktion af maniske symptomer over 3 uger i forhold til placebo og valproat.
English: Hydrochloric acid.
Danish: Indeholder lactosemonohydrat.
English: In clinical trials, clinically meaningful QTc prolongations (Fridericia QT correction [QTcF] ≥ 500 milliseconds [msec] at any time post baseline in patients with baseline QTcF < 500 msec) were uncommon (0.1 % to 1 %) in patients treated with olanzapine, with no significant differences in associated cardiac events compared to placebo.
Danish: QTc-forlængelse blev defineret som Fridericia korrigeret QT (QTcF) ≥500 millisekunder (msek) på et hvilket som helst tidspunkt post-baseline hos patienter med baseline QTcF <500 msek.
English: ZYPREXA 10 mg coated tablets Round, white, coated tablets imprinted with “LILLY” and a numeric identicode “4117”.
Danish: ZYPREXA 10 mg overtrukne tabletter Runde, hvide, overtrukne tabletter præget med "LILLY" samt en talkode "4117".
English: Powder for Solution for Injection.
Danish: Pulver til injektionsvæske, opløsning.
English: In clinical trials with oral administration, clinically meaningful QTc prolongations (Fridericia QT correction [QTcF] ≥ 500 milliseconds [msec] at any time post baseline in patients with baseline QTcF < 500 msec) were uncommon (0.1 % to 1 %) in patients treated with olanzapine, with no significant differences in associated cardiac events compared to placebo.
Danish: I kliniske forsøg med oral administration var klinisk betydningsfulde QTc-forlængelser usædvanlige (0,1% til 1%) hos de patienter, som blev behandlet med olanzapin.
English: ZYPREXA 10 mg coated tablets are white imprinted with “LILLY” and a numeric identicode “4117”.
Danish: ZYPREXA 10 mg overtrukne tabletter er hvide og mærket med ”LILLY” samt talkoden ”4117”.
English: Excipient with known effect: Each coated tablet contains 178 mg lactose monohydrate.
Danish: Hjælpestof, som behandleren skal være opmærksom på: Hver overtrukken tablet indeholder 178 mg lactosemonohydrat.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each coated tablet contains 7.5 mg olanzapine
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hver overtrukken tablet indeholder 7,5 mg olanzapin
English: Excipient with known effect: Each coated tablet contains 156 mg lactose monohydrate.
Danish: Hjælpestof, som behandleren skal være opmærksom på: Hver overtrukken tablet indeholder 156 mg lactosemonohydrat.
English: ZYPREXA contains lactose
Danish: ZYPREXA indeholder lactose.
English: ZYPREXA 20 mg coated tablets
Danish: ZYPREXA 20 mg overtrukne tabletter
English: ZYPREXA coated tablets are for oral use.
Danish: ZYPREXA overtrukne tabletter er til at synke.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ZYPREXA 7.5 mg COATED TABLETS: BLISTER FOIL LABEL
Danish: MINDSTEKRAV TIL MÆRKNING PÅ BLISTER ELLER STRIP ZYPREXA 7,5 mg OVERTRUKNE TABLETTER: BLISTERFOLIE
English: INFORMATION IN BRAILLE ZYPREXA 7.5 mg
Danish: ZYPREXA 7,5 mg
English: ZYPREXA Injection belongs to a group of medicines called antipsychotics and is used to treat symptoms of agitation and distressing behaviour that may occur in the following conditions:
Danish: De bruges til at behandle symptomer som uro, ophidselse og uhensigtsmæssig opførsel, som kan forekomme ved følgende lidelser:
English: Excipient with known effect: Each coated tablet contains 102 mg lactose monohydrate.
Danish: Hjælpestof, som behandleren skal være opmærksom på: Hver overtrukken tablet indeholder 102 mg lactosemonohydrat.
English: ZYPREXA 7.5 mg coated tablets Round, white, coated tablets imprinted with “LILLY” and a numeric identicode “4116”.
Danish: ZYPREXA 7,5 mg overtrukne tabletter Runde, hvide, overtrukne tabletter præget med "LILLY" samt en talkode "4116".
English: NAME OF THE MEDICINAL PRODUCT ZYPREXA 10 mg powder for solution for injection olanzapine
Danish: ZYPREXA 10 mg pulver til injektionsvæske, opløsning Olanzapin
English: ZYPREXA 5 mg coated tablets Round, white, coated tablets imprinted with “LILLY” and a numeric identicode “4115”.
Danish: ZYPREXA 5 mg overtrukne tabletter Runde, hvide, overtrukne tabletter præget med "LILLY" samt en talkode "4115".
English: ZYPREXA 7.5 mg coated tablets are white imprinted with “LILLY” and a numeric identicode “4116”.
Danish: ZYPREXA 7,5 mg overtrukne tabletter er hvide og mærket med ”LILLY” samt talkoden ”4116”.
English: Other uncommon side effects (may affect up to 1 in 100 people) include hypersensitivity (e.g. swelling in the mouth and throat, itching, rash): diabetes or the worsening of diabetes, occasionally associated with ketoacidosis (ketones in the blood and urine) or coma; seizures, usually associated with a history of seizures (epilepsy); muscle stiffness or spasms (including eye movements); restless legs syndrome; problems with speech; stuttering; slow heart rate; sensitivity to sunlight; bleeding from nose; abdominal distension; memory loss or forgetfulness; urinary incontinence; lack of ability to urinate; hair loss; absence or decrease in menstrual periods; and changes in breasts in males and females such as an abnormal production of breast milk or abnormal growth.
Danish: Andre ikke almindelige bivirkninger (forekommer hos op til 1 ud af 100 patienter) omfatter overfølsomhed (f.eks. hævelser i mund og hals, kløe, hududslæt); sukkersyge eller forværring af sukkersyge, af og til ledsaget af syreforgiftning (ketoacidose - ketonstoffer i blod og urin) eller bevidstløshed; krampeanfald, sædvanligvis hos patienter med tidligere krampeanfald (epilepsi); muskelstivhed eller muskelkramper (inklusive øjenbevægelser); restless legs-syndrom (stærk uro i underbenene); problemer med at tale; stammen; langsom hjertefrekvens (puls); følsomhed overfor sollys; næseblod; udspilet mave; hukommelsestab eller glemsomhed; ufrivillig vandladning (urininkontinens); vandladningsbesvær; hårtab; manglende menstruation eller længere intervaller mellem menstruationerne; brystforandringer hos mænd og kvinder, såsom unormal produktion af brystmælk eller unormal vækst.
English: Excipient with known effect: Each coated tablet contains 312 mg lactose monohydrate.
Danish: Hjælpestof, som behandleren skal være opmærksom på: Hver overtrukken tablet indeholder 312 mg lactosemonohydrat.
English: PHARMACEUTICAL FORM Powder for solution for injection Yellow lyophilised powder.
Danish: LÆGEMIDDELFORM Pulver til injektionsvæske, opløsning.
English: Other common side effects(may affect up to 1 in 10 people) include changes in the levels of some blood cells, circulating fats and early in treatment, temporary increases in liver enzymes; increases in the level of sugars in the blood and urine; increases in levels of uric acid and creatine phosphokinase in the blood; feeling more hungry; dizziness; restlessness; tremor; unusual movements (dyskinesias); constipation; dry mouth; rash; loss of strength; extreme tiredness; water retention leading to swelling of the hands, ankles or feet; fever; joint pain; and sexual dysfunctions such as decreased libido in males and females or erectile dysfunction in males.
Danish: Andre almindelige bivirkninger (forekommer hos op til 1 ud af 10 patienter) omfatter ændringer i mængden af visse blodceller, cirkulerende fedtstoffer i blodet samt forbigående forhøjede leverenzymer tidligt i behandlingen; forhøjet sukker i blodet og urinen; forhøjet urinsyre og kreatinkinase i blodet; øget sultfornemmelse; svimmelhed; rastløshed; rysten; unormale bevægelser (dyskinesi); forstoppelse; mundtørhed; hududslæt; tab af styrke; udpræget træthed; væskeophobning som medfører hævede hænder, ankler eller fødder; feber; ledsmerter og seksuelle problemer såsom nedsat sexlyst (libido) hos mænd og kvinder eller rejsningsbesvær hos mænd.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each coated tablet contains 20 mg olanzapine
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hver overtrukken tablet indeholder 20 mg olanzapin
English: Alopecia
Danish: Olanzapin
English: ZYPREXA 5 mg coated tablets are white imprinted with “LILLY” and a numeric identicode “4115”.
Danish: ZYPREXA 5 mg overtrukne tabletter er hvide og mærket med ”LILLY” samt talkoden ”4115”.
English: The most frequently (seen in ≥ 1% of patients) reported adverse reactions associated with the use of olanzapine in clinical trials were somnolence, weight gain, eosinophilia, elevated prolactin, cholesterol, glucose and triglyceride levels (see section 4.4), glucosuria, increased appetite, dizziness, akathisia, parkinsonism, leukopenia, neutropenia (see section 4.4), dyskinesia, orthostatic hypotension, anticholinergic effects, transient asymptomatic elevations of hepatic aminotransferases (see section 4.4), rash, asthenia, fatigue, pyrexia, arthralgia, increased alkaline phosphatase, high gamma glutamyltransferase, high uric acid, high creatine phosphokinase and oedema.
Danish: De hyppigst rapporterede (set hos ≥ 1 % af patienter) bivirkninger, som blev set i forbindelse med anvendelse af olanzapin i kliniske forsøg, var døsighed og vægtøgning, eosinofili, forhøjede niveauer af prolaktin, kolesterol, glucose og triglycerider (se pkt.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each coated tablet contains 2.5 mg olanzapine
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hver overtrukken tablet indeholder 2,5 mg olanzapin
English: Excipient with known effect: Each coated tablet contains 234 mg lactose monohydrate.
Danish: Hjælpestof, som behandleren skal være opmærksom på: Hver overtrukken tablet indeholder 234 mg lactosemonohydrat.
English: Common side effects (may affect up to 1 in 10 people) include changes in the levels of some blood cells, circulating fats and early in treatment, temporary increases in liver enzymes; increases in the level of sugars in the blood and urine; increases in levels of uric acid and creatine phosphokinase in the blood; feeling more hungry; dizziness; restlessness; tremor; unusual movements(dyskinesias); constipation; dry mouth; rash; loss of strength; extreme tiredness; water retention leading to swelling of the hands, ankles or feet; fever; joint pain; and sexual dysfunctions such as decreased libido in males and females or erectile dysfunction in males.
Danish: Almindelige bivirkninger (forekommer hos op til 1 ud af 10 patienter) omfatter ændringer i mængden af visse blodceller, cirkulerende fedtstoffer i blodet samt forbigående forhøjede leverenzymer tidligt i behandlingen; forhøjet sukker i blodet og urinen; forhøjet urinsyre og kreatinkinase i blodet; øget sultfornemmelse; svimmelhed; rastløshed; rysten; unormale bevægelser (dyskinesi); forstoppelse; mundtørhed; hududslæt; tab af styrke; udpræget træthed; væskeophobning, som medfører hævede hænder, ankler eller fødder; feber; ledsmerter og seksuelle problemer såsom nedsat sexlyst (libido) hos mænd og kvinder eller rejsningsbesvær hos mænd
English: 5 Observed for fasting normal levels at baseline (< 1.69 mmol/l) which increased to high
Danish: 5 Observeret for fastende normalt niveau ved baseline (< 1,69 mmol/l), der blev øget til højt niveau (≥ 2,26 mmol/l).
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ZYPREXA 2.5 mg COATED TABLETS: BLISTER FOIL LABEL
Danish: MINDSTEKRAV TIL MÆRKNING PÅ BLISTER ELLER STRIP ZYPREXA 2,5 mg OVERTRUKNE TABLETTER: BLISTERFOLIE
English: Other medicines and ZYPREXA
Danish: Rekonstitution og administration af ZYPREXA
English: Excipient with known effect: Each coated tablet conatins 238 mg lactose monohydrate.
Danish: Hjælpestof, som behandleren skal være opmærksom på: Hver overtrukken tablet indeholder 238 mg lactosemonohydrat.
English: Each coated tablet contains 20 mg olanzapine.
Danish: ZYPREXA 20 mg overtrukne tabletter Hver overtrukken tablet indeholder 20 mg olanzapin.
English: NAME OF THE MEDICINAL PRODUCT ZYPREXA 15 mg coated tablets Olanzapine
Danish: LÆGEMIDLETS NAVN ZYPREXA 15 mg overtrukne tabletter Olanzapin
English: What ZYPREXA Injection looks like and contents of the pack ZYPREXA comes as a yellow powder in a vial.
Danish: ZYPREXA er et gult pulver i et hætteglas.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ZYPREXA 20 mg COATED TABLETS: BLISTER FOIL LABEL
Danish: MINDSTEKRAV TIL MÆRKNING PÅ BLISTER ELLER STRIP ZYPREXA 20 mg OVERTRUKNE TABLETTER: BLISTERFOLIE
English: In a multinational, double-blind, comparative study of schizophrenia, schizoaffective, and related disorders which included 1,481 patients with varying degrees of associated depressive symptoms (baseline mean of 16.6 on the Montgomery-Asberg Depression Rating Scale), a prospective secondary analysis of baseline to endpoint mood score change demonstrated a statistically significant improvement (p = 0.001) favouring olanzapine (-6.0) versus haloperidol (-3.1).
Danish: Studiet viste en prospektiv sekundær analyse af ændring i stemningslejeniveauet fra før behandling til endt behandling en statistisk signifikant forbedring (p=0,001) til fordel for patienter behandlet med olanzapin (-6,0) i forhold til patienter behandlet med haloperidol (-3,1).
English: ZYPREXA 5 mg coated tablets
Danish: ZYPREXA 5 mg overtrukne tabletter
English: Each coated tablet contains 7.5 mg olanzapine.
Danish: ZYPREXA 7,5 mg overtrukne tabletter Hver overtrukken tablet indeholder 7,5 mg olanzapin.
English: EU/1/96/022/011 - ZYPREXA - 7.5 mg - coated tablets - 28 tablets, per box.
Danish: EU/1/96/022/011 - ZYPREXA - 7,5 mg - overtrukne tabletter - 28 tabletter pr. karton.
English: MARKETING AUTHORISATION NUMBER (S) EU/1/96/022/016 Powder for solution for injection.
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (NUMRE) EU/1/96/022/016 Pulver til injektionsvæske, opløsning 1 hætteglas EU/1/96/022/017 Pulver til injektionsvæske, opløsning 10 hætteglas 13.
English: EU/1/96/022/006 - ZYPREXA - 7.5 mg - coated tablets - 56 tablets, per box.
Danish: EU/1/96/022/006 - ZYPREXA - 7,5 mg - overtrukne tabletter - 56 tabletter pr. karton.
English: Each coated tablet contains 10 mg olanzapine.
Danish: ZYPREXA 10 mg overtrukne tabletter Hver overtrukken tablet indeholder 10 mg olanzapin.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each coated tablet contains 10 mg olanzapine
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hver overtrukken tablet indeholder 10 mg olanzapin
English: ZYPREXA 15 mg coated tablets
Danish: ZYPREXA 15 mg overtrukne tabletter
English: Each coated tablet contains 2.5 mg olanzapine.
Danish: ZYPREXA 2,5 mg overtrukne tabletter Hver overtrukken tablet indeholder 2,5 mg olanzapin.
English: EU/1/96/022/029 - ZYPREXA - 2.5 mg - coated tablets - 70 tablets, per box.
Danish: EU/1/96/022/029 - ZYPREXA - 2,5 mg - overtrukne tabletter - 70 tabletter pr. karton.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each coated tablet contains 15 mg olanzapine
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hver overtrukken tablet indeholder 15 mg olanzapin
English: In a multinational, double-blind, comparative study of schizophrenia, schizoaffective, and related disorders which included 1,481 patients with varying degrees of associated depressive symptoms (baseline mean of 16.6 on the Montgomery-Asberg Depression Rating Scale), a prospective secondary analysis of baseline to endpoint mood score change demonstrated a statistically significant improvement (p= 0.001) favouring olanzapine (-6.0) versus haloperidol (-3.1).
Danish: Studiet omfattede 1.481 patienter med varierende grad af hertil forbundne depressive symptomer (middelværdi før behandling lig 16,6 ved Montgomery-Asberg Depression Rating Scale).
English: EU/1/96/022/037 - ZYPREXA - 7.5 mg - coated tablets - 98 tablets, per box.
Danish: EU/1/96/022/037 - ZYPREXA - 7,5 mg - overtrukne tabletter - 98 tabletter pr. karton.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each vial contains 10 mg olanzapine.
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hvert hætteglas indeholder 10 mg olanzapin.
English: SPECIAL STORAGE CONDITIONS Do not store above 25º C. Store in original package in order to protect from light
Danish: SÆRLIGE OPBEVARINGSBETINGELSER Må ikke opbevares ved temperaturer over 25 °C.
English: EU/1/96/022/033 - ZYPREXA - 15 mg - coated tablets - 70 tablets, per box.
Danish: EU/1/96/022/033 - ZYPREXA - 15 mg - overtrukne tabletter - 70 tabletter pr. karton.
English: EU/1/96/022/031 - ZYPREXA - 7.5 mg - coated tablets - 70 tablets, per box.
Danish: EU/1/96/022/031 - ZYPREXA - 7,5 mg - overtrukne tabletter - 70 tabletter pr. karton.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each coated tablet contains 5 mg olanzapine
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hver overtrukken tablet indeholder 5 mg olanzapin
English: EU/1/96/022/035 - ZYPREXA - 2.5 mg - coated tablets - 98 tablets, per box.
Danish: EU/1/96/022/035 - ZYPREXA - 2,5 mg - overtrukne tabletter - 98 tabletter pr. karton.
English: EU/1/96/022/009 - ZYPREXA - 10 mg - coated tablets - 28 tablets, per box.
Danish: EU/1/96/022/009 - ZYPREXA - 10 mg - overtrukne tabletter - 28 tabletter pr. karton.
English: EU/1/96/022/034 - ZYPREXA - 20 mg - coated tablets - 70 tablets, per box.
Danish: EU/1/96/022/034 - ZYPREXA - 20 mg - overtrukne tabletter - 70 tabletter pr. karton.
English: Each coated tablet contains 15 mg olanzapine.
Danish: ZYPREXA 15 mg overtrukne tabletter Hver overtrukken tablet indeholder 15 mg olanzapin.
English: NAME OF THE MEDICINAL PRODUCT ZYPREXA 7.5 mg coated tablets olanzapine
Danish: ZYPREXA 7,5 mg overtrukne tabletter Olanzapin
English: EU/1/96/022/023 - ZYPREXA - 2.5 mg - coated tablets - 35 tablets, per box.
Danish: EU/1/96/022/023 - ZYPREXA - 2,5 mg - overtrukne tabletter - 35 tabletter pr. karton.
English: Vascular Disorders
Danish: Vaskulære sygdomme Ortostatisk
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ZYPREXA 15 mg COATED TABLETS: BLISTER FOIL LABEL
Danish: MINDSTEKRAV TIL MÆRKNING PÅ BLISTER ELLER STRIP ZYPREXA 15 mg OVERTRUKNE TABLETTER: BLISTERFOLIE
English: EU/1/96/022/025 - ZYPREXA - 7.5 mg - coated tablets - 35 tablets, per box.
Danish: EU/1/96/022/025 - ZYPREXA - 7,5 mg - overtrukne tabletter - 35 tabletter pr. karton.
English: Eli Lilly Nederland B.V. Tel: + 31 (0)30 6025800
Danish: Tel: + 31(0)30 6025800
English: EU/1/96/022/002 - ZYPREXA - 2.5 mg - coated tablets - 28 tablets, per box.
Danish: EU/1/96/022/002 - ZYPREXA - 2,5 mg - overtrukne tabletter - 28 tabletter pr. karton.
English: EU/1/96/022/032 - ZYPREXA - 10 mg - coated tablets - 70 tablets, per box.
Danish: EU/1/96/022/032 - ZYPREXA - 10 mg - overtrukne tabletter - 70 tabletter pr. karton.
English: Respiratory disorders
Danish: Krampeanfald
English: EU/1/96/022/012 - ZYPREXA - 15 mg - coated tablets - 28 tablets, per box.
Danish: EU/1/96/022/012 - ZYPREXA - 15 mg - overtrukne tabletter - 28 tabletter pr. karton.
English: EU/1/96/022/028 - ZYPREXA - 20 mg - coated tablets - 35 tablets, per box.
Danish: EU/1/96/022/028 - ZYPREXA - 20 mg - overtrukne tabletter - 35 tabletter pr. karton.
English: EU/1/96/022/019 - ZYPREXA - 2.5 mg - coated tablets - 56 tablets, per box.
Danish: EU/1/96/022/019 - ZYPREXA - 2,5 mg - overtrukne tabletter - 56 tabletter pr. karton.
English: EU/1/96/022/040 - ZYPREXA - 20 mg - coated tablets - 98 tablets, per box.
Danish: EU/1/96/022/040 - ZYPREXA - 20 mg - overtrukne tabletter - 98 tabletter pr. karton.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ZYPREXA 10 mg COATED TABLETS: BLISTER FOIL LABEL
Danish: MINDSTEKRAV TIL MÆRKNING PÅ BLISTER ELLER STRIP ZYPREXA 10 mg OVERTRUKNE TABLETTER: BLISTERFOLIE
English: EU/1/96/022/027 - ZYPREXA - 15 mg - coated tablets - 35 tablets, per box.
Danish: EU/1/96/022/027 - ZYPREXA - 15 mg - overtrukne tabletter - 35 tabletter pr. karton.
English: EU/1/96/022/004 - ZYPREXA - 5 mg - coated tablets - 28 tablets, per box.
Danish: EU/1/96/022/004 - ZYPREXA - 5 mg - overtrukne tabletter - 28 tabletter pr. karton.
English: EU/1/96/022/014 - ZYPREXA - 20 mg - coated tablets - 28 tablets, per box.
Danish: EU/1/96/022/014 - ZYPREXA - 20 mg - overtrukne tabletter - 28 tabletter pr. karton.
English: INFORMATION IN BRAILLE ZYPREXA 2.5 mg
Danish: ZYPREXA 2,5 mg
English: EU/1/96/022/038 - ZYPREXA - 10 mg - coated tablets - 98 tablets, per box.
Danish: EU/1/96/022/038 - ZYPREXA - 10 mg - overtrukne tabletter - 98 tabletter pr. karton.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ZYPREXA 5 mg COATED TABLETS: BLISTER FOIL LABEL
Danish: MINDSTEKRAV TIL MÆRKNING PÅ BLISTER ELLER STRIP ZYPREXA 5 mg OVERTRUKNE TABLETTER: BLISTERFOLIE
English: EU/1/96/022/039 - ZYPREXA - 15 mg - coated tablets - 98 tablets, per box.
Danish: EU/1/96/022/039 - ZYPREXA - 15 mg - overtrukne tabletter - 98 tabletter pr. karton.
English: EU/1/96/022/022 - ZYPREXA - 20 mg - coated tablets - 56 tablets, per box.
Danish: EU/1/96/022/022 - ZYPREXA - 20 mg - overtrukne tabletter - 56 tabletter pr. karton.
English: EU/1/96/022/024 - ZYPREXA - 5 mg - coated tablets - 35 tablets, per box.
Danish: EU/1/96/022/024 - ZYPREXA - 5 mg - overtrukne tabletter - 35 tabletter pr. karton.
English: EU/1/96/022/021 - ZYPREXA - 15 mg - coated tablets - 56 tablets, per box.
Danish: EU/1/96/022/021 - ZYPREXA - 15 mg - overtrukne tabletter - 56 tabletter pr. karton.
English: INFORMATION IN BRAILLE ZYPREXA 20 mg
Danish: ZYPREXA 20 mg
English: EU/1/96/022/026 - ZYPREXA - 10 mg - coated tablets - 35 tablets, per box.
Danish: EU/1/96/022/026 - ZYPREXA - 10 mg - overtrukne tabletter - 35 tabletter pr. karton.
English: EU/1/96/022/030 - ZYPREXA - 5 mg - coated tablets - 70 tablets, per box.
Danish: EU/1/96/022/030 - ZYPREXA - 5 mg - overtrukne tabletter - 70 tabletter pr. karton.
English: NAME OF THE MEDICINAL PRODUCT ZYPREXA 2.5 mg coated tablets olanzapine
Danish: ZYPREXA 2,5 mg overtrukne tabletter Olanzapin